{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:15:11Z","timestamp":1789604111383,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T00:00:00Z","timestamp":1439769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T00:00:00Z","timestamp":1439769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1038\/gt.2015.90","type":"journal-article","created":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T14:40:38Z","timestamp":1439822438000},"page":"214-222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The targeted inhibitory effects of human amniotic fluid stem cells carrying CXCR4 promoter and DAL-1 on non-small cell lung carcinoma growth"],"prefix":"10.1038","volume":"23","author":[{"given":"L","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,17]]},"reference":[{"key":"BFgt201590_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.thorsurg.2013.01.015","volume":"23","author":"C Dresler","year":"2013","unstructured":"Dresler C . The changing epidemic of lung cancer and occupational and environmental risk factors. Thorac Surg Clin 2013; 23: 113\u2013122.","journal-title":"Thorac Surg Clin"},{"key":"BFgt201590_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A . Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11\u201330.","journal-title":"CA Cancer J Clin"},{"key":"BFgt201590_CR3","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s13277-012-0452-x","volume":"33","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Xu R, Li G, Xie X, Long J, Wang H . Loss of expression of the differentially expressed in adenocarcinoma of the lung (DAL-1) protein is associated with metastasis of non-small cell lung carcinoma cells. Tumour Biol 2012; 33: 1915\u20131925.","journal-title":"Tumour Biol"},{"key":"BFgt201590_CR4","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1158\/1535-7163.MCT-05-0334","volume":"5","author":"S Komarova","year":"2006","unstructured":"Komarova S, Kawakami Y, Stoff-Khalili MA, Curiel DT, Pereboeva L . Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses. Mol Cancer Ther 2006; 5: 755\u2013766.","journal-title":"Mol Cancer Ther"},{"key":"BFgt201590_CR5","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nrc948","volume":"2","author":"EA Chiocca","year":"2002","unstructured":"Chiocca EA . Oncolytic viruses. Nat Rev Cancer 2002; 2: 938\u2013950.","journal-title":"Nat Rev Cancer"},{"key":"BFgt201590_CR6","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/sj.cgt.7700548","volume":"9","author":"R Vile","year":"2002","unstructured":"Vile R, Ando D, Kirn D . The oncolytic virotherapy treatment platform for cancer: unique biological and biosafety points to consider. Cancer Gene Ther 2002; 9: 1062\u20131067.","journal-title":"Cancer Gene Ther"},{"key":"BFgt201590_CR7","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.amjsurg.2012.02.016","volume":"204","author":"L Armstrong","year":"2012","unstructured":"Armstrong L, Arrington A, Han J, Gavrikova T, Brown E, Yamamoto M et al. Generation of a novel, cyclooxygenase-2-targeted, interferon-expressing, conditionally replicative adenovirus for pancreatic cancer therapy. Am J Surg 2012; 204: 741\u2013750.","journal-title":"Am J Surg"},{"key":"BFgt201590_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1476-4598-10-133","volume":"10","author":"HN Xu","year":"2011","unstructured":"Xu HN, Huang WD, Cai Y, Ding M, Gu JF, Wei N et al. HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy. Mol Cancer 2011; 10: 133.","journal-title":"Mol Cancer"},{"key":"BFgt201590_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4103\/2277-9175.124645","volume":"3","author":"M Nikzaban","year":"2014","unstructured":"Nikzaban M, Hakhamaneshi MS, Fakhari S, Sheikhesmaili F, Roshani D, Ahsan B et al. The chemokine receptor CXCR4 is associated with the staging of gastric cancer. Adv Biomed Res 2014; 3: 16.","journal-title":"Adv Biomed Res"},{"key":"BFgt201590_CR10","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1007\/s13277-013-1603-4","volume":"35","author":"M Han","year":"2014","unstructured":"Han M, Lv S, Zhang Y, Yi R, Huang B, Fu H et al. The prognosis and clinicopathology of CXCR4 in gastric cancer patients: a meta-analysis. Tumour Biol 2014; 35: 4589\u20134597.","journal-title":"Tumour Biol"},{"key":"BFgt201590_CR11","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.jcyt.2013.06.010","volume":"15","author":"WY Lee","year":"2013","unstructured":"Lee WY, Zhang T, Lau CP, Wang CC, Chan KM, Li G . Immortalized human fetal bone marrow-derived mesenchymal stromal cell expressing suicide gene for anti-tumor therapy in vitro and in vivo. Cytotherapy 2013; 15: 1484\u20131497.","journal-title":"Cytotherapy"},{"key":"BFgt201590_CR12","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1021\/mp200649g","volume":"9","author":"WC Hsiao","year":"2012","unstructured":"Hsiao WC, Sung SY, Liao CH, Wu HC, Hsieh CL . Vitamin D3-inducible mesenchymal stem cell-based delivery of conditionally replicating adenoviruses effectively targets renal cell carcinoma and inhibits tumor growth. Mol Pharm 2012; 9: 1396\u20131408.","journal-title":"Mol Pharm"},{"key":"BFgt201590_CR13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3324\/haematol.11869","volume":"93","author":"N Sessarego","year":"2008","unstructured":"Sessarego N, Parodi A, Podesta M, Benvenuto F, Mogni M, Raviolo V et al. Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. Haematologica 2008; 93: 339\u2013346.","journal-title":"Haematologica"},{"key":"BFgt201590_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5483\/BMBRep.2014.47.3.289","volume":"47","author":"EY Kim","year":"2014","unstructured":"Kim EY, Lee KB, Kim MK . The potential of mesenchymal stem cells derived from amniotic membrane and amniotic fluid for neuronal regenerative therapy. BMB Rep 2014; 47: 135\u2013140.","journal-title":"BMB Rep"},{"key":"BFgt201590_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.expneurol.2014.01.015","volume":"254","author":"D Bottai","year":"2014","unstructured":"Bottai D, Scesa G, Cigognini D, Adami R, Nicora E, Abrignani S et al. Third trimester NG2-positive amniotic fluid cells are effective in improving repair in spinal cord injury. Exp Neurol 2014; 254: 121\u2013133.","journal-title":"Exp Neurol"},{"key":"BFgt201590_CR16","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1172\/JCI9762","volume":"105","author":"C Heise","year":"2000","unstructured":"Heise C, Kirn DH . Replication-selective adenoviruses as oncolytic agents. J Clin Invest 2000; 105: 847\u2013851.","journal-title":"J Clin Invest"},{"key":"BFgt201590_CR17","doi-asserted-by":"publisher","first-page":"e87900","DOI":"10.1371\/journal.pone.0087900","volume":"9","author":"K Shien","year":"2014","unstructured":"Shien K, Tanaka N, Watanabe M, Soh J, Sakaguchi M, Matsuo K et al. Anti-cancer effects of REIC\/Dkk-3-encoding adenoviral vector for the treatment of non-small cell lung cancer. PLoS One 2014; 9: e87900.","journal-title":"PLoS One"},{"key":"BFgt201590_CR18","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ygyno.2013.06.003","volume":"130","author":"KH Kim","year":"2013","unstructured":"Kim KH, Dmitriev IP, Saddekni S, Kashentseva EA, Harris RD, Aurigemma R et al. A phase I clinical trial of Ad5\/3-Delta24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer. Gynecol Oncol 2013; 130: 518\u2013524.","journal-title":"Gynecol Oncol"},{"key":"BFgt201590_CR19","first-page":"5129","volume":"62","author":"M Yageta","year":"2002","unstructured":"Yageta M, Kuramochi M, Masuda M, Fukami T, Fukuhara H, Maruyama T et al. Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer. Cancer Res 2002; 62: 5129\u20135133.","journal-title":"Cancer Res"},{"key":"BFgt201590_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1023\/B:HIJO.0000039848.86488.74","volume":"35","author":"N Terada","year":"2004","unstructured":"Terada N, Ohno N, Yamakawa H, Baba T, Fujii Y, Ohara O et al. Immunolocalization of protein 4.1B in the rat digestive system. J Mol Histol 2004; 35: 347\u2013353.","journal-title":"J Mol Histol"},{"key":"BFgt201590_CR21","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1242\/jcs.000273","volume":"120","author":"T Cavanna","year":"2007","unstructured":"Cavanna T, Pokorna E, Vesely P, Gray C, Zicha D . Evidence for protein 4.1B acting as a metastasis suppressor. J Cell Sci 2007; 120: 606\u2013616.","journal-title":"J Cell Sci"},{"key":"BFgt201590_CR22","doi-asserted-by":"publisher","first-page":"8783","DOI":"10.1158\/0008-5472.CAN-07-0357","volume":"67","author":"ME Wohlfahrt","year":"2007","unstructured":"Wohlfahrt ME, Beard BC, Lieber A, Kiem HP . A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models. Cancer Res 2007; 67: 8783\u20138790.","journal-title":"Cancer Res"},{"key":"BFgt201590_CR23","first-page":"199","volume":"15","author":"M Pozzobon","year":"2014","unstructured":"Pozzobon M, Piccoli M, De Coppi P . Stem cells from fetal membranes and amniotic fluid: markers for cell isolation and therapy. Cell Tissue Bank 2014; 15: 199\u2013211.","journal-title":"Cell Tissue Bank"},{"key":"BFgt201590_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2174\/1574888X11308020004","volume":"8","author":"V Bitsika","year":"2013","unstructured":"Bitsika V, Vlahou A, Roubelakis MG . Fetal mesenchymal stem cells in cancer therapy. Curr Stem Cell Res Ther 2013; 8: 133\u2013143.","journal-title":"Curr Stem Cell Res Ther"},{"key":"BFgt201590_CR25","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.3892\/mmr.2014.1989","volume":"9","author":"XY Si","year":"2014","unstructured":"Si XY, Li JJ, Yao T, Wu XY . Transforming growth factor-beta1 in the microenvironment of ischemia reperfusion-injured kidney enhances the chemotaxis of mesenchymal stem cells to stromal cell-derived factor-1 through upregulation of surface chemokine (C-X-C motif) receptor 4. Mol Med Rep 2014; 9: 1794\u20131798.","journal-title":"Mol Med Rep"},{"key":"BFgt201590_CR26","doi-asserted-by":"publisher","first-page":"130763","DOI":"10.1155\/2013\/130763","volume":"2013","author":"A Sohni","year":"2013","unstructured":"Sohni A, Verfaillie CM . Mesenchymal stem cells migration homing and tracking. Stem Cells Int 2013; 2013: 130763.","journal-title":"Stem Cells Int"},{"key":"BFgt201590_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1258\/ebm.2011.010234","volume":"236","author":"S Rajendran","year":"2011","unstructured":"Rajendran S, O'Hanlon D, Morrissey D, O'Donovan T, O'Sullivan GC, Tangney M . Preclinical evaluation of gene delivery methods for the treatment of loco-regional disease in breast cancer. Exp Biol Med (Maywood) 2011; 236: 423\u2013434.","journal-title":"Exp Biol Med (Maywood)"},{"key":"BFgt201590_CR28","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1158\/1078-0432.CCR-10-1628","volume":"17","author":"SW Yang","year":"2011","unstructured":"Yang SW, Cody JJ, Rivera AA, Waehler R, Wang M, Kimball KJ et al. Conditionally replicating adenovirus expressing TIMP2 for ovarian cancer therapy. Clin Cancer Res 2011; 17: 538\u2013549.","journal-title":"Clin Cancer Res"},{"key":"BFgt201590_CR29","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1158\/0008-5472.CAN-12-3086","volume":"73","author":"N Shinojima","year":"2013","unstructured":"Shinojima N, Hossain A, Takezaki T, Fueyo J, Gumin J, Gao F et al. TGF-beta mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells. Cancer Res 2013; 73: 2333\u20132344.","journal-title":"Cancer Res"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201590.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201590","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201590.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T13:10:36Z","timestamp":1648559436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,17]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["BFgt201590"],"URL":"https:\/\/doi.org\/10.1038\/gt.2015.90","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,17]]},"assertion":[{"value":"30 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}